Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
OncoNano Medicine
AddedFeb 15, 2024
UpdatedJun 18, 2026
OncoNano Medicine

OncoNano Medicine

Public

Texas-based OncoNano Medicine develops pH-activated compounds for cancer, Alzheimer's, and metabolic disorders.

HQ
Southlake, TX, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

OncoNano Medicine, founded in Texas, is a clinical-stage biotechnology company focused on transforming cancer therapeutics through its proprietary nanotechnology platform. The company's core mission is to leverage pH-activated compounds to develop advanced therapeutics and imaging technologies for cancer, Alzheimer's, and metabolic disorders. OncoNano's flagship technology, the ON-BOARDâ„¢ polymeric micelle platform, aims to precisely deliver anti-tumor payloads to the tumor microenvironment, enhancing the efficacy and specificity of cancer treatments.

Notable affiliated individuals include scientific leaders and industry experts who contribute to OncoNano's innovative approach. The company has attracted significant investment from key venture capital firms, underscoring confidence in its technology. Among its achievements, OncoNano has developed a differentiated pipeline of novel therapies that have shown promise in preclinical and early clinical trials. The company's impact lies in its potential to revolutionize cancer treatment by improving targeting accuracy and reducing side effects, thereby enhancing patient outcomes.

OncoNano Medicine - Similar Companies

Nanospectra Biosciences logo

Nanospectra Biosciences

nanospectra.com

NanoMedTrix logo

NanoMedTrix

Duo Oncology logo

Duo Oncology

duooncology.com

NanoPharmaceuticals logo

NanoPharmaceuticals

Advanced NanoTherapies logo

Advanced NanoTherapies

NanoHybrids logo

NanoHybrids

nanohybrids.net

Nano Cures logo

Nano Cures

nanocures.com

OncXerna Therapeutics logo

OncXerna Therapeutics

oncxerna.com

OncoSpherix logo

OncoSpherix

oncospherix.com

NanoMedical Systems logo

NanoMedical Systems

nanomedsys.com

Nanocan Therapeutics logo

Nanocan Therapeutics

OncoSenX logo

OncoSenX

oncosenx.com

Vali Nanomedical logo

Vali Nanomedical

OncoResponse logo

OncoResponse

Cello Therapeutics logo

Cello Therapeutics

cellothera.com

OncoNano Medicine - Quick Facts

Who are OncoNano Medicine's competitors?

Companies similar to OncoNano Medicine include Nanospectra Biosciences, NanoMedTrix, Duo Oncology and NanoPharmaceuticals.

When was OncoNano Medicine founded?

OncoNano Medicine was founded in 2014.

Where is OncoNano Medicine's headquarters located?

OncoNano Medicine's headquarters is located in Southlake, TX, US.

When was OncoNano Medicine's last funding round?

OncoNano Medicine's most recent funding round was for $18.4M (USD) in October 2021.

How much has OncoNano Medicine raised to-date?

As of Oct 25, 2021, OncoNano Medicine has raised a total of $188.1M (USD).

How many employees does OncoNano Medicine have?

OncoNano Medicine has 29 employees as of Feb 5, 2024.

OncoNano Medicine - Classification

Ownership
  • Public
  • Venture Capital
Technology
  • Biotech
  • Nanotechnology
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Imaging Technology
  • Nanotechnology
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified